| Melissa Berg Hostetter, MD | |
|
108 Community Dr, Waynesboro, VA 22980-9505 | |
| (540) 949-0118 | |
| (540) 949-8903 |
| Full Name | Melissa Berg Hostetter |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 108 Community Dr, Waynesboro, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033113956 | NPI | - | NPPES |
| 54741 | Other | OPTIMA | |
| 2213464 | Other | FIRST HEALTH | |
| 240285 | Other | SOUTHERN HEALTH | |
| 010054290 | Medicaid | VA | |
| 6265006 | Other | CIGNA | |
| 113534 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101231843 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Berg Hostetter, MD 108 Community Dr, Waynesboro, VA 22980-9505 Ph: (540) 949-0118 | Melissa Berg Hostetter, MD 108 Community Dr, Waynesboro, VA 22980-9505 Ph: (540) 949-0118 |
News Archive
Epilepsy drug-switching study shows that using more ethical control groups could be the way forward for testing both drug efficacy and safety
Researchers developed a platform for detecting the virus directly from a patient's sample as well as the immune response through antibodies such as IgG and IgM.
CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in bone and cartilage repair. Financial details were not disclosed.
Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest.
› Verified 8 days ago
Dr. Nathan Allen Ostheimer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Community Dr, Waynesboro, VA 22980 Phone: 540-949-0118 Fax: 540-932-2059 | |
Dr. Kurtis Lamar Sauder, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Community Dr, Waynesboro, VA 22980 Phone: 540-949-0118 Fax: 540-949-8903 | |
Dr. Robert J Fern, M.D. PHD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Community Dr, Waynesboro, VA 22980 Phone: 540-949-0118 Fax: 540-949-8903 | |
Peter R Devries, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Community Dr, Waynesboro, VA 22980 Phone: 540-949-0118 Fax: 540-949-8903 | |
Hannah Lawrence, LAT, ATC Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 W Main St, Waynesboro, VA 22980 Phone: 540-946-4616 | |
Dr. George Thomas Sproul, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Community Dr, Waynesboro, VA 22980 Phone: 540-949-0118 Fax: 540-949-8903 |